HomeCompareSTLC vs JNJ

STLC vs JNJ: Dividend Comparison 2026

STLC yields 4.72% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STLC wins by $7.2K in total portfolio value
10 years
STLC
STLC
● Live price
4.72%
Share price
$42.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.3K
Annual income
$639.11
Full STLC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — STLC vs JNJ

📍 STLC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTLCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STLC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STLC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STLC
Annual income on $10K today (after 15% tax)
$401.47/yr
After 10yr DRIP, annual income (after tax)
$543.24/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $160.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STLC + JNJ for your $10,000?

STLC: 50%JNJ: 50%
100% JNJ50/50100% STLC
Portfolio after 10yr
$23.6K
Annual income
$733.44/yr
Blended yield
3.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STLC
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STLC buys
0
JNJ buys
0
No recent congressional trades found for STLC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTLCJNJ
Forward yield4.72%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$27.3K$20.0K
Annual income after 10y$639.11$827.78
Total dividends collected$5.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STLC vs JNJ ($10,000, DRIP)

YearSTLC PortfolioSTLC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,172$472.31$10,676$355.77+$496.00STLC
2$12,448$493.16$11,407$389.39+$1.0KSTLC
3$13,832$513.50$12,198$426.53+$1.6KSTLC
4$15,334$533.30$13,056$467.62+$2.3KSTLC
5$16,960$552.52$13,987$513.12+$3.0KSTLC
6$18,718$571.13$14,998$563.56+$3.7KSTLC
7$20,618$589.10$16,098$619.52+$4.5KSTLC
8$22,667$606.43$17,295$681.69+$5.4KSTLC
9$24,877$623.10$18,599$750.82+$6.3KSTLC
10$27,257$639.11$20,022$827.78+$7.2KSTLC

STLC vs JNJ: Complete Analysis 2026

STLCStock

The investment seeks to track the investment results of the Russell US Large Cap Factors Blend Style Index. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The underlying index is designed to select equity securities from the Russell 1000 Index, with exposure to five equity style factors (momentum, quality, value, size and low volatility) while maintaining a level of risk similar to that of the parent index. It is non-diversified.

Full STLC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this STLC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STLC vs SCHDSTLC vs JEPISTLC vs OSTLC vs KOSTLC vs MAINSTLC vs ABBVSTLC vs MRKSTLC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.